Pharmaceutical Drugs MGR 2017
July 2017
250
About the Report
About the Report
The market segments in the pharmaceuticals drugs sector as of 2016 were Oncology, Anti-diabetics, Anti-rheumatics, Anti-virals, Vaccines, Bronchodilators, Sensory Organs, Anti-hypertensives, MS Therapies, Immunosuppressants, Anti-coagulants, Dermatologicals, Anti-hyperlipidaemics, Anti-fibrinolytics and Anti-bacterials.
Pharmaceuticals Drugs was the largest segment in the pharmaceuticals market with over 80% share of the market. Pharmaceuticals Drugs are chemical substances used to treat, cure, prevent or diagnose a disease. Biologics was the second largest segment in the pharmaceuticals market with around 20% share of the market. Biologics comprises products such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins extracted or semi synthesized from biological sources.
The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.
Rise of Biologics/Gene Therapy was observed to be one of the top trends in the pharmaceuticals industry as of 2016. Advances in genetics, molecular biology and gene delivery technologies have led to an increase in gene therapies to treat a number of diseases. Gene therapy treatment includes the isolation and transfer of stem cell populations, administration of effector cells and induction of pluripotent cells. Applications of gene therapy and biologics are primarily in cancer, cardiovascular and central nervous system diseases. Gene therapy is being widely used by healthcare service providers as it has the potential to cure hereditary diseases such as cystic fibrosis and also has the scope to treat heart diseases and cancer. For instance, cancer gene therapy is expected to be around $4.3 billion, thus indicating high demand for gene therapy
The Pharmaceutical Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs sector.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceuticals market, and compares it with other markets.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
The pharmaceutical drugs market section of the report gives context. It compares the pharmaceutical drugs market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.
The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Cardiovascular Disorders, Dermatology, Gastrointestinal Diseases, Genito-Urinary Disorders, Hematology, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Central Nervous System, Oncology, Ophthalmology, Respiratory Diseases
Companies Mentioned: Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Products
Products
Cardiovascular Drugs, Dermatological Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Drugs For Infectious Diseases, Drugs For Metabolic Disorders, Drugs For Musculoskeletal Disorders, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Drugs For Respiratory Diseases
Companies
Johnson & Johnson, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi
Table of Contents
Table of Contents
1. Pharmaceutical Drugs Market Characteristics;
2. Pharmaceutical Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs Market Customer Information;
5. Pharmaceutical Drugs Market Segmentation;
5.1. Global Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 5.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment; 5.3. Global Pharmaceutical Drugs Market Trends And Strategies; 5.4. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016; 5.5. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast; 5.6. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region; 5.7. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country; 5.8. Cardiovascular Disorders; 5.8.1. Market Characteristics; 5.8.2. Global Cardiovascular Disorders Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9. Dermatology; 5.9.1. Market Characteristics; 5.9.2. Global Dermatology Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10. Gastrointestinal Diseases; 5.10.1. Market Characteristics; 5.10.2. Global Gastrointestinal Diseases Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11. Genito-urinary Disorders; 5.11.1. Market Characteristics; 5.11.2. Global Genito-urinary Disorders Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12. Hematology; 5.12.1. Market Characteristics; 5.12.2. Global Hematology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13. Infectious Diseases; 5.13.1. Market Characteristics; 5.13.2. Global Infectious Diseases Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14. Metabolic Disorders; 5.14.1. Market Characteristics; 5.14.2. Global Metabolic Disorders Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 5.15. Musculoskeletal Disorders; 5.15.1. Market Characteristics; 5.15.2. Global Musculoskeletal Disorders Market, 2016, By Segment; 5.15.3. Market Trends And Strategies; 5.16. Central Nervous System; 5.16.1. Market Characteristics; 5.16.2. Global Central Nervous System Market, 2016, By Segment; 5.16.3. Market Trends And Strategies; 5.17. Oncology; 5.17.1. Market Characteristics; 5.17.2. Global Oncology Market, 2016, By Segment; 5.17.3. Market Trends And Strategies; 5.18. Ophthalmology; 5.18.1. Market Characteristics; 5.18.2. Global Ophthalmology Market, 2016, By Segment; 5.18.3. Market Trends And Strategies; 5.19. Respiratory Diseases; 5.19.1. Market Characteristics; 5.19.2. Global Respiratory Diseases Market, 2016, By Segment; 5.19.3. Market Trends And Strategies;
6. Pharmaceutical Drugs Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs Market, 2016, By Country; 6.4. Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global;
8. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country;
9. Pharmaceutical Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Global Number Of General Practitioners 2016, By Country; 9.10. Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis; 10.3. China Pharmaceutical Drugs Market; 10.3.1. China Pharmaceutical Drugs Market Overview; 10.3.2. China Pharmaceutical Drugs Historic Market, 2012-2016; 10.3.3. China Pharmaceutical Drugs Forecast Market, 2016-2020; 10.3.4. China Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.3.5. China Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.4. India Pharmaceutical Drugs Market; 10.4.1. India Pharmaceutical Drugs Market Overview; 10.4.2. India Pharmaceutical Drugs Historic Market, 2012-2016; 10.4.3. India Pharmaceutical Drugs Forecast Market, 2016-2020; 10.4.4. India Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.4.5. India Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.5. Japan Pharmaceutical Drugs Market; 10.5.1. Japan Pharmaceutical Drugs Market Overview; 10.5.2. Japan Pharmaceutical Drugs Historic Market, 2012-2016; 10.5.3. Japan Pharmaceutical Drugs Forecast Market, 2016-2020; 10.5.4. Japan Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.5.5. Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 10.6. Australia Pharmaceutical Drugs Market; 10.6.1. Australia Pharmaceutical Drugs Historic Market, 2012-2016; 10.6.2. Australia Pharmaceutical Drugs Forecast Market, 2016-2020; 10.6.3. Australia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.6.4. Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;
11. Western Europe Pharmaceutical Drugs Market;
11.1.1. Western Europe Pharmaceutical Drugs Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2012-2016; 11.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020; 11.1.4. Western Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.2. Western Europe Pharmaceutical Drugs Market: Country Analysis; 11.3. UK Pharmaceutical Drugs Market; 11.3.1. UK Pharmaceutical Drugs Market Overview; 11.3.2. UK Pharmaceutical Drugs Historic Market, 2012-2016; 11.3.3. UK Pharmaceutical Drugs Forecast Market, 2016-2020; 11.3.4. UK Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.3.5. UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.4. Germany Pharmaceutical Drugs Market; 11.4.1. Germany Pharmaceutical Drugs Historic Market, 2012-2016; 11.4.2. Germany Pharmaceutical Drugs Forecast Market, 2016-2020; 11.4.3. Germany Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.4.4 Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.5 France Pharmaceutical Drugs Market; 11.5.1 France Pharmaceutical Drugs Historic Market, 2012-2016; 11.5.2 France Pharmaceutical Drugs Forecast Market, 2016-2020; 11.5.3 France Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.5.4 France Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.6. Italy Pharmaceutical Drugs Market; 11.6.1. Italy Pharmaceutical Drugs Historic Market, 2012-2016; 11.6.2. Italy Pharmaceutical Drugs Forecast Market, 2016-2020; 11.6.3. Italy Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 11.6.4. Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020; 11.7. Spain Pharmaceutical Drugs Market; 11.7.1. Spain Pharmaceutical Drugs Historic Market, 2012-2016; 11.7.2. Spain Pharmaceutical Drugs Forecast Market, 2016-2020; 11.7.3. Spain Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.7.4. Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;
12. Eastern Europe Pharmaceutical Drugs Market;
12.1.1. Eastern Europe Pharmaceutical Drugs Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016; 12.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020; 12.1.4 Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs Market; 12.3. Russia Pharmaceutical Drugs Market; 12.3.1. Russia Pharmaceutical Drugs Historic Market, 2012-2016; 12.3.2. Russia Pharmaceutical Drugs Forecast Market, 2016-2020; 12.3.3. Russia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.3.4. Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;
13. North America Pharmaceutical Drugs Market;
13.1.1. North America Pharmaceutical Drugs Market Overview; 13.1.2. North America Pharmaceutical Drugs Historic Market, 2012-2016; 13.1.3. North America Pharmaceutical Drugs Forecast Market, 2016-2020; 13.1.4. North America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 13.2. North America Pharmaceutical Drugs Market: Country Analysis; 13.3. USA Pharmaceutical Drugs Market; 13.3.1. USA Pharmaceutical Drugs Historic Market, 2012-2016; 13.3.2. USA Pharmaceutical Drugs Forecast Market, 2016-2020; 13.3.3 USA Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases13.3.4. USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;
14. South America Pharmaceutical Drugs Market;
14.1.1. South America Pharmaceutical Drugs Market Overview; 14.1.2. South America Pharmaceutical Drugs Historic Market, 2012-2016; 14.1.3. South America Pharmaceutical Drugs Forecast Market, 2016-2020; 14.1.4. South America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.2. South America Pharmaceutical Drugs Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs Market; 14.3.1. Brazil Pharmaceutical Drugs Historic Market, 2012-2016; 14.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2016-2020; 14.3.3. Brazil Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.3.4. Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020;
15. Middle East Pharmaceutical Drugs Market;
15.1.1. Middle East Pharmaceutical Drugs Market Overview; 15.1.2. Middle East Pharmaceutical Drugs Historic Market, 2012-2016; 15.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2016-2020; 15.1.4. Middle East Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
16. Africa Pharmaceutical Drugs Market;
16.1.1. Africa Pharmaceutical Drugs Market Overview; 16.1.2. Africa Pharmaceutical Drugs Historic Market, 2012-2016; 16.1.3. Africa Pharmaceutical Drugs Forecast Market, 2016-2020; 16.1.4. Africa Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
17. Pharmaceutical Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
19. Market Background: Pharmaceuticals Market;
19.1.1. Pharmaceuticals Market Characteristics; 19.1.2. Pharmaceuticals Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceuticals Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceuticals Trends And Strategies; 19.2. Pharmaceuticals Market Regional And Country Analysis; 19.2.1. Global Pharmaceuticals Market, 2016, By Region; 19.2.2. Pharmaceuticals Market, 2016, By Country; 19.2.3. Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country; 19.2.4. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceuticals Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceuticals Expenditure, Global; 19.4. Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceuticals Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceuticals Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceuticals Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
List of Figure
Table 1: Global Pharmaceutical Drugs Historic Market Growth
Table 2: Global Pharmaceutical Drugs Forecast Market Growth
Table 3: Pharmaceutical Drugs Market Segmentation
Table 4: Global Pharmaceutical Drugs Market, 2016, By Segment
Table 5: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment
Table 6: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016
Table 7: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Table 8: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region
Table 9: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country
Table 10: Global Cardiovascular Disorders Market, 2016, By Segment
Table 11: Global Dermatology Market, 2016, By Segment
Table 12: Global Gastrointestinal Diseases Market, 2016, By Segment
Table 13: Global Genito-urinary Disorders Market, 2016, By Segment
Table 14: Global Hematology Market, 2016, By Segment
Table 15: Global Infectious Diseases Market, 2016, By Segment
Table 16: Global Metabolic Disorders Market, 2016, By Segment
Table 17: Global Musculoskeletal Disorders Market, 2016, By Segment
Table 18: Global Central Nervous System Market, 2016, By Segment
Table 19: Global Oncology Market, 2016, By Segment
Table 20: Global Ophthalmology Market, 2016, By Segment
Table 21: Global Respiratory Diseases Market, 2016, By Segment
Table 22: Global Pharmaceutical Drugs Market, 2016, By Region
Table 23: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region
Table 24: Pharmaceutical Drugs Market, 2016, By Country
Table 25: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country
Table 26: Global Healthcare Market Segments, 2016, By Region;
Table 27: Global Pharmaceutical Market Segments, 2016, By Region;
Table 28: Global Healthcare Market Segments, 2016, By Country;
Table 29: Global Pharmaceutical Market Segments, 2016, By Country;
Table 30: Global Pharmaceuticals Market Segments, 2016, By Region
Table 31: Global Pharmaceutical Drugs Market Segments, 2016, By Region
Table 32: Global Pharmaceuticals Market Segments, 2016, By Country
Table 33: Global Pharmaceutical Drugs Market Segments, 2016, By Country
Table 34: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
Table 35: Per Capita Average Pharmaceutical Drugs Expenditure, Global
Table 36: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
Table 37: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
Table 38: Per Capita Average Pharmaceutical Drugs Expenditure, By Country
Table 39: Global Number Of Pharmacists, 2016, By Country
Table 40: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country
Table 41: Global Number Of Pharma Enterprises, 2016, By Country
Table 42: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
Table 43: Global Average Spending On R&D/Product Development, 2016, By Country
Table 44: Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
Table 45: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
Table 46: Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
Table 47: Global Number Of General Practitioners 2016, By Country
Table 48: Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country
Table 49: Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016
Table 50: Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020
Table 51: Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment
Table 52: China Pharmaceutical Drugs Historic Market, 2012-2016
Table 53: China Pharmaceutical Drugs Forecast Market, 2016-2020
Table 54: China Pharmaceutical Drugs Market, 2016, By Segment
Table 55: China Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 56: China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 57: India Pharmaceutical Drugs Historic Market, 2012-2016
Table 58: India Pharmaceutical Drugs Forecast Market, 2016-2020
Table 59: India Pharmaceutical Drugs Market, 2016, By Segment
Table 60: India Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 61: India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 62: Japan Pharmaceutical Drugs Historic Market, 2012-2016
Table 63: Japan Pharmaceutical Drugs Forecast Market, 2016-2020
Table 64: Japan Pharmaceutical Drugs Market, 2016, By Segment
Table 65: Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 66: Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 67: Australia Pharmaceutical Drugs Historic Market, 2012-2016
Table 68: Australia Pharmaceutical Drugs Forecast Market, 2016-2020
Table 69: Australia Pharmaceutical Drugs Market, 2016, By Segment
Table 70: Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 71: Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 72: Western Europe Pharmaceutical Drugs Historic Market, 2012-2016
Table 73: Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020
Table 74: Western Europe Pharmaceutical Drugs Market, 2016, By Segment
Table 75: UK Pharmaceutical Drugs Historic Market, 2012-2016
Table 76: UK Pharmaceutical Drugs Forecast Market, 2016-2020
Table 77: UK Pharmaceutical Drugs Market, 2016, By Segment
Table 78: UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 79: UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 80: Germany Pharmaceutical Drugs Historic Market, 2012-2016
Table 81: Germany Pharmaceutical Drugs Forecast Market, 2016-2020
Table 82: Germany Pharmaceutical Drugs Market, 2016, By Segment
Table 83: Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 84: Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 85: France Pharmaceutical Drugs Historic Market, 2012-2016
Table 86: France Pharmaceutical Drugs Forecast Market, 2016-2020
Table 87: France Pharmaceutical Drugs Market, 2016, By Segment
Table 88: France Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 89: France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 90: Italy Pharmaceutical Drugs Historic Market, 2012-2016
Table 91: Italy Pharmaceutical Drugs Forecast Market, 2016-2020
Table 92: Italy Pharmaceutical Drugs Market, 2016, By Segment
Table 93: Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 94: Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 95: Spain Pharmaceutical Drugs Historic Market, 2012-2016
Table 96: Spain Pharmaceutical Drugs Forecast Market, 2016-2020
Table 97: Spain Pharmaceutical Drugs Market, 2016, By Segment
Table 98: Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 99: Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 100: Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016
Table 101: Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020
Table 102: Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment
Table 103: Russia Pharmaceutical Drugs Historic Market, 2012-2016
Table 104: Russia Pharmaceutical Drugs Forecast Market, 2016-2020
Table 105: Russia Pharmaceutical Drugs Market, 2016, By Segment
Table 106: Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 107: Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 108: North America Pharmaceutical Drugs Historic Market, 2012-2016
Table 109: North America Pharmaceutical Drugs Forecast Market, 2016-2020
Table 110: North America Pharmaceutical Drugs Market, 2016, By Segment
Table 111: USA Pharmaceutical Drugs Historic Market, 2012-2016
Table 112: USA Pharmaceutical Drugs Forecast Market, 2016-2020
Table 113: USA Pharmaceutical Drugs Market, 2016, By Segment
Table 114: USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 115: USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 116: South America Pharmaceutical Drugs Historic Market, 2012-2016
Table 117: South America Pharmaceutical Drugs Forecast Market, 2016-2020
Table 118: South America Pharmaceutical Drugs Market, 2016, By Segment
Table 119: Brazil Pharmaceutical Drugs Historic Market, 2012-2016
Table 120: Brazil Pharmaceutical Drugs Forecast Market, 2016-2020
Table 121: Brazil Pharmaceutical Drugs Market, 2016, By Segment
Table 122: Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Table 123: Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Table 124: Middle East Pharmaceutical Drugs Historic Market, 2012-2016
Table 125: Middle East Pharmaceutical Drugs Forecast Market, 2016-2020
Table 126: Middle East Pharmaceutical Drugs Market, 2016, By Segment
Table 127: Africa Pharmaceutical Drugs Historic Market, 2012-2016
Table 128: Africa Pharmaceutical Drugs Forecast Market, 2016-2020
Table 129: Africa Pharmaceutical Drugs Market, 2016, By Segment
Table 130: Johnson & Johnson Financial Performance
Table 131: Novartis Ag Financial Performance
Table 132: F. Hoffmann-La Roche Ltd Financial Performance
Table 133: Pfizer Inc. Financial Performance
Table 134: Sanofi Financial Performance
Table 135: Pharmaceuticals Market Historic Growth
Table 136: Pharmaceuticals Market Forecast Growth
Table 137: Global Pharmaceuticals Market, 2016, By Region
Table 138: Global Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Region
Table 139: Pharmaceuticals Market, 2016, By Country
Table 140: Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country
Table 141: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment
Table 142: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment
Table 143: Pharmaceuticals Market Size, Percentage Of GDP, Global
Table 144: Per Capita Average Pharmaceuticals Expenditure, Global
Table 145: Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries
Table 146: Pharmaceuticals Market Size, Percentage Of GDP, By Country
Table 147: Per Capita Average Pharmaceuticals Expenditure, By Country
Table 148: Healthcare Industry Financial Margins
List of Table
Figure 1: Global Pharmaceutical Drugs Historic Market Growth
Figure 2: Global Pharmaceutical Drugs Forecast Market Growth
Figure 3: Pharmaceutical Drugs Market Segmentation
Figure 4: Global Pharmaceutical Drugs Market, 2016, By Segment
Figure 5: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Segment
Figure 6: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016
Figure 7: Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Figure 8: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region
Figure 9: Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country
Figure 10: Global Cardiovascular Disorders Market, 2016, By Segment
Figure 11: Global Dermatology Market, 2016, By Segment
Figure 12: Global Gastrointestinal Diseases Market, 2016, By Segment
Figure 13: Global Genito-urinary Disorders Market, 2016, By Segment
Figure 14: Global Hematology Market, 2016, By Segment
Figure 15: Global Infectious Diseases Market, 2016, By Segment
Figure 16: Global Metabolic Disorders Market, 2016, By Segment
Figure 17: Global Musculoskeletal Disorders Market, 2016, By Segment
Figure 18: Global Central Nervous System Market, 2016, By Segment
Figure 19: Global Oncology Market, 2016, By Segment
Figure 20: Global Ophthalmology Market, 2016, By Segment
Figure 21: Global Respiratory Diseases Market, 2016, By Segment
Figure 22: Global Pharmaceutical Drugs Market, 2016, By Region
Figure 23: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region
Figure 24: Pharmaceutical Drugs Market, 2016, By Country
Figure 25: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country
Figure 26: Global Healthcare Market Segments, 2016, By Region;
Figure 27: Global Pharmaceutical Market Segments, 2016, By Region;
Figure 28: Global Healthcare Market Segments, 2016, By Country;
Figure 29: Global Pharmaceutical Market Segments, 2016, By Country;
Figure 30: Global Pharmaceuticals Market Segments, 2016, By Region
Figure 31: Global Pharmaceutical Drugs Market Segments, 2016, By Region
Figure 32: Global Pharmaceuticals Market Segments, 2016, By Country
Figure 33: Global Pharmaceutical Drugs Market Segments, 2016, By Country
Figure 34: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
Figure 35: Per Capita Average Pharmaceutical Drugs Expenditure, Global
Figure 36: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
Figure 37: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
Figure 38: Per Capita Average Pharmaceutical Drugs Expenditure, By Country
Figure 39: Global Number Of Pharmacists, 2016, By Country
Figure 40: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country
Figure 41: Global Number Of Pharma Enterprises, 2016, By Country
Figure 42: Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
Figure 43: Global Average Spending On R&D/Product Development, 2016, By Country
Figure 44: Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
Figure 45: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
Figure 46: Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
Figure 47: Global Number Of General Practitioners 2016, By Country
Figure 48: Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country
Figure 49: Asia-Pacific Pharmaceutical Drugs Historic Market, 2012-2016
Figure 50: Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 51: Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment
Figure 52: China Pharmaceutical Drugs Historic Market, 2012-2016
Figure 53: China Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 54: China Pharmaceutical Drugs Market, 2016, By Segment
Figure 55: China Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 56: China Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 57: India Pharmaceutical Drugs Historic Market, 2012-2016
Figure 58: India Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 59: India Pharmaceutical Drugs Market, 2016, By Segment
Figure 60: India Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 61: India Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 62: Japan Pharmaceutical Drugs Historic Market, 2012-2016
Figure 63: Japan Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 64: Japan Pharmaceutical Drugs Market, 2016, By Segment
Figure 65: Japan Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 66: Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 67: Australia Pharmaceutical Drugs Historic Market, 2012-2016
Figure 68: Australia Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 69: Australia Pharmaceutical Drugs Market, 2016, By Segment
Figure 70: Australia Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 71: Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 72: Western Europe Pharmaceutical Drugs Historic Market, 2012-2016
Figure 73: Western Europe Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 74: Western Europe Pharmaceutical Drugs Market, 2016, By Segment
Figure 75: UK Pharmaceutical Drugs Historic Market, 2012-2016
Figure 76: UK Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 77: UK Pharmaceutical Drugs Market, 2016, By Segment
Figure 78: UK Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 79: UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 80: Germany Pharmaceutical Drugs Historic Market, 2012-2016
Figure 81: Germany Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 82: Germany Pharmaceutical Drugs Market, 2016, By Segment
Figure 83: Germany Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 84: Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 85: France Pharmaceutical Drugs Historic Market, 2012-2016
Figure 86: France Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 87: France Pharmaceutical Drugs Market, 2016, By Segment
Figure 88: France Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 89: France Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 90: Italy Pharmaceutical Drugs Historic Market, 2012-2016
Figure 91: Italy Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 92: Italy Pharmaceutical Drugs Market, 2016, By Segment
Figure 93: Italy Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 94: Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 95: Spain Pharmaceutical Drugs Historic Market, 2012-2016
Figure 96: Spain Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 97: Spain Pharmaceutical Drugs Market, 2016, By Segment
Figure 98: Spain Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 99: Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 100: Eastern Europe Pharmaceutical Drugs Historic Market, 2012-2016
Figure 101: Eastern Europe Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 102: Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment
Figure 103: Russia Pharmaceutical Drugs Historic Market, 2012-2016
Figure 104: Russia Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 105: Russia Pharmaceutical Drugs Market, 2016, By Segment
Figure 106: Russia Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 107: Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 108: North America Pharmaceutical Drugs Historic Market, 2012-2016
Figure 109: North America Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 110: North America Pharmaceutical Drugs Market, 2016, By Segment
Figure 111: USA Pharmaceutical Drugs Historic Market, 2012-2016
Figure 112: USA Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 113: USA Pharmaceutical Drugs Market, 2016, By Segment
Figure 114: USA Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 115: USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 116: South America Pharmaceutical Drugs Historic Market, 2012-2016
Figure 117: South America Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 118: South America Pharmaceutical Drugs Market, 2016, By Segment
Figure 119: Brazil Pharmaceutical Drugs Historic Market, 2012-2016
Figure 120: Brazil Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 121: Brazil Pharmaceutical Drugs Market, 2016, By Segment
Figure 122: Brazil Pharmaceutical Drugs Percentage Of GDP, 2012-2020
Figure 123: Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012-2020
Figure 124: Middle East Pharmaceutical Drugs Historic Market, 2012-2016
Figure 125: Middle East Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 126: Middle East Pharmaceutical Drugs Market, 2016, By Segment
Figure 127: Africa Pharmaceutical Drugs Historic Market, 2012-2016
Figure 128: Africa Pharmaceutical Drugs Forecast Market, 2016-2020
Figure 129: Africa Pharmaceutical Drugs Market, 2016, By Segment
Figure 130: Johnson & Johnson Financial Performance
Figure 131: Novartis Ag Financial Performance
Figure 132: F. Hoffmann-La Roche Ltd Financial Performance
Figure 133: Pfizer Inc. Financial Performance
Figure 134: Sanofi Financial Performance
Figure 135: Pharmaceuticals Market Historic Growth
Figure 136: Pharmaceuticals Market Forecast Growth
Figure 137: Global Pharmaceuticals Market, 2016, By Region
Figure 138: Global Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Region
Figure 139: Pharmaceuticals Market, 2016, By Country
Figure 140: Pharmaceuticals Market, 2012-2020, Historic And Forecast, By Country
Figure 141: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment
Figure 142: Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment
Figure 143: Pharmaceuticals Market Size, Percentage Of GDP, Global
Figure 144: Per Capita Average Pharmaceuticals Expenditure, Global
Figure 145: Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries
Figure 146: Pharmaceuticals Market Size, Percentage Of GDP, By Country
Figure 147: Per Capita Average Pharmaceuticals Expenditure, By Country
Figure 148: Healthcare Industry Financial Margins
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.